[Prolonged survival following human pulmonary transplantation].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D004417:Dyspnea / Q000209:etiology; D005839:Gentamicins / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000188:drug therapy; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008168:Lung / Q000503:physiopathology; D008170:Lung Compliance; D016040:Lung Transplantation; D008297:Male; D011013:Pneumonectomy; D011183:Postoperative Complications; D011379:Prognosis; D018805:Sepsis / Q000188:drug therapy; D012829:Silicosis / Q000601:surgery; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014797:Vital Capacity
D000305:Adrenal Cortex Hormones; D005839:Gentamicins; D007166:Immunosuppressive Agents
Survie prolongée après transplantation pulmonaire chez l'homme.